Binding optimization through coordination chemistry: CXCR4 chemokine receptor antagonists from ultrarigid metal complexes

Abid Khan*, Gary Nicholson, John Greenman, Leigh Madden, Graeme McRobbie, Christophe Pannecouque, Erik De Clercq, Robert Ullom, Danny L. Maples, Randall D. Maples, Jon D. Silversides, Timothy J. Hubin, Stephen J. Archibald

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

81 Citations (Scopus)

Abstract

A new copper(II) containing bis-macrocyclic CXCR4 chemokine receptor antagonist is shown to have improved binding properties to the receptor protein in comparison to the drug AMD3100 (Plerixafor, Mozobil). The interaction of the metallodrug has been optimized by using ultrarigid chelator units that offer an equatorial site for coordination to the amino acid side chains of the protein. Binding competition assays with anti-CXCR4 antibodies show that the new compound stays bound longer and it has improved anti-HIV potency in vitro (EC 50 = 4.3 nM). X-ray structural studies using acetate as a model for carboxylate amino acid side chains indicate the nature of the coordination interaction.

Original languageEnglish
Pages (from-to)3416-3417
Number of pages2
JournalJournal of the American Chemical Society
Volume131
Issue number10
DOIs
Publication statusPublished - 18 Mar 2009

Fingerprint

Dive into the research topics of 'Binding optimization through coordination chemistry: CXCR4 chemokine receptor antagonists from ultrarigid metal complexes'. Together they form a unique fingerprint.

Cite this